Logo image of ALHRS.PA

HYDROGEN REFUELING SOLUTIONS (ALHRS.PA) Stock Fundamental Analysis

EPA:ALHRS - FR0014001PM5 - Common Stock

2.95 EUR
0 (-0.17%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

ALHRS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 105 industry peers in the Machinery industry. ALHRS may be in some trouble as it scores bad on both profitability and health. ALHRS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ALHRS has reported negative net income.
In the past year ALHRS has reported a negative cash flow from operations.
In the past 5 years ALHRS always reported negative net income.
ALHRS had a negative operating cash flow in each of the past 5 years.
ALHRS.PA Yearly Net Income VS EBIT VS OCF VS FCFALHRS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M -25M

1.2 Ratios

ALHRS has a Return On Assets of -12.93%. This is amonst the worse of the industry: ALHRS underperforms 82.86% of its industry peers.
ALHRS's Return On Equity of -38.12% is on the low side compared to the rest of the industry. ALHRS is outperformed by 82.86% of its industry peers.
Industry RankSector Rank
ROA -12.93%
ROE -38.12%
ROIC N/A
ROA(3y)-4.43%
ROA(5y)-6.1%
ROE(3y)-9.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALHRS.PA Yearly ROA, ROE, ROICALHRS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

ALHRS has a worse Gross Margin (16.58%) than 86.67% of its industry peers.
ALHRS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALHRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.93%
GM growth 5Y-17.71%
ALHRS.PA Yearly Profit, Operating, Gross MarginsALHRS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

ALHRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALHRS has more shares outstanding
ALHRS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALHRS has a worse debt to assets ratio.
ALHRS.PA Yearly Shares OutstandingALHRS.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALHRS.PA Yearly Total Debt VS Total AssetsALHRS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ALHRS has an Altman-Z score of 0.46. This is a bad value and indicates that ALHRS is not financially healthy and even has some risk of bankruptcy.
ALHRS has a Altman-Z score of 0.46. This is in the lower half of the industry: ALHRS underperforms 73.33% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that ALHRS is somewhat dependend on debt financing.
ALHRS's Debt to Equity ratio of 0.52 is in line compared to the rest of the industry. ALHRS outperforms 40.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 0.46
ROIC/WACCN/A
WACC6.77%
ALHRS.PA Yearly LT Debt VS Equity VS FCFALHRS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.09 indicates that ALHRS should not have too much problems paying its short term obligations.
The Current ratio of ALHRS (1.09) is worse than 79.05% of its industry peers.
A Quick Ratio of 1.07 indicates that ALHRS should not have too much problems paying its short term obligations.
ALHRS has a Quick ratio of 1.07. This is comparable to the rest of the industry: ALHRS outperforms 50.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.07
ALHRS.PA Yearly Current Assets VS Current LiabilitesALHRS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

ALHRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.67%.
Looking at the last year, ALHRS shows a very negative growth in Revenue. The Revenue has decreased by -39.69% in the last year.
The Revenue has been growing by 33.81% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-122.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.59%
Revenue 1Y (TTM)-39.69%
Revenue growth 3Y33.19%
Revenue growth 5Y33.81%
Sales Q2Q%-42.63%

3.2 Future

The Earnings Per Share is expected to grow by 18.91% on average over the next years. This is quite good.
ALHRS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 52.33% yearly.
EPS Next Y-38.71%
EPS Next 2Y16.57%
EPS Next 3Y18.91%
EPS Next 5YN/A
Revenue Next Year-11.27%
Revenue Next 2Y17.7%
Revenue Next 3Y27.33%
Revenue Next 5Y52.33%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHRS.PA Yearly Revenue VS EstimatesALHRS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
ALHRS.PA Yearly EPS VS EstimatesALHRS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALHRS. In the last year negative earnings were reported.
Also next year ALHRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALHRS.PA Price Earnings VS Forward Price EarningsALHRS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALHRS.PA Per share dataALHRS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

ALHRS's earnings are expected to grow with 18.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.57%
EPS Next 3Y18.91%

0

5. Dividend

5.1 Amount

ALHRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HYDROGEN REFUELING SOLUTIONS

EPA:ALHRS (9/5/2025, 7:00:00 PM)

2.95

0 (-0.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)10-07 2025-10-07/amc
Inst Owners2.86%
Inst Owner ChangeN/A
Ins Owners66.88%
Ins Owner ChangeN/A
Market Cap45.61M
Analysts85
Price Target5.1 (72.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.68%
PT rev (3m)-14.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-43.93%
EPS NY rev (3m)-43.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.36
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS1.25
BVpS2.65
TBVpS2.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.93%
ROE -38.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.58%
FCFM N/A
ROA(3y)-4.43%
ROA(5y)-6.1%
ROE(3y)-9.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.93%
GM growth 5Y-17.71%
F-Score2
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.83%
Cap/Sales 24.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.07
Altman-Z 0.46
F-Score2
WACC6.77%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)55.45%
Cap/Sales(5y)37.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.59%
EPS Next Y-38.71%
EPS Next 2Y16.57%
EPS Next 3Y18.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-39.69%
Revenue growth 3Y33.19%
Revenue growth 5Y33.81%
Sales Q2Q%-42.63%
Revenue Next Year-11.27%
Revenue Next 2Y17.7%
Revenue Next 3Y27.33%
Revenue Next 5Y52.33%
EBIT growth 1Y-120.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.62%
EBIT Next 3Y28.36%
EBIT Next 5YN/A
FCF growth 1Y70.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.12%
OCF growth 3YN/A
OCF growth 5YN/A